HomeSRDX • NASDAQ
Surmodics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 28.09M | -12.12% |
Operating expense | 13.40M | -4.09% |
Net income | -5.21M | -2,208.91% |
Net profit margin | -18.55 | -2,509.09% |
Earnings per share | -0.13 | -285.71% |
EBITDA | 629.00K | -77.17% |
Effective tax rate | -11.26% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 31.15M | -23.92% |
Total assets | 163.21M | -10.72% |
Total liabilities | 52.97M | -10.00% |
Total equity | 110.25M | — |
Shares outstanding | 14.30M | — |
Price to book | 3.82 | — |
Return on assets | -2.31% | — |
Return on capital | -2.62% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -5.21M | -2,208.91% |
Cash from operations | 949.00K | -87.20% |
Cash from investing | -2.28M | -181.52% |
Cash from financing | 48.00K | 111.85% |
Net change in cash | -962.00K | -109.94% |
Free cash flow | 3.66M | -46.95% |
Previous close
$29.48
Day range
$29.44 - $30.34
Year range
$26.00 - $42.44
Market cap
429.01M USD
Avg Volume
79.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1979
Headquarters
Website
Employees
389